BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35776113)

  • 1. Resveratrol plus low-dose hydroxyurea compared to high-dose hydroxyurea alone is more effective in
    Alipour M; Nasiri N; Kazemi F; Zare F; Sharifzadeh S
    Nat Prod Res; 2023 Mar; 37(6):985-989. PubMed ID: 35776113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression.
    Zhu J; Chin K; Aerbajinai W; Kumkhaek C; Li H; Rodgers GP
    Blood; 2014 Aug; 124(7):1146-56. PubMed ID: 24914133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP response element-binding protein 1 is required for hydroxyurea-mediated induction of γ-globin expression in K562 cells.
    Banan M; Esmaeilzadeh-Gharehdaghi E; Nezami M; Deilami Z; Farashi S; Philipsen S; Esteghamat F; Pourfarzad F; Ali Imam AM; Najmabadi H
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):510-7. PubMed ID: 22469229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
    Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
    Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of low-dose hydroxyurea with sodium butyrate on globin gene expression in human erythroid progenitor cells].
    Wu QQ; Qian XH; Xu MJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2073-6, 2081. PubMed ID: 19861270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through
    Parsasefat M; Safarpour H; Nomiri S; Miri-Moghaddam E
    Hemoglobin; 2022 May; 46(3):153-159. PubMed ID: 35506261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
    Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
    Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea generates nitric oxide in human erythroid cells: mechanisms for gamma-globin gene activation.
    Lou TF; Singh M; Mackie A; Li W; Pace BS
    Exp Biol Med (Maywood); 2009 Nov; 234(11):1374-82. PubMed ID: 19657070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydroxyurea-induced small GTP-binding protein SAR modulates gamma-globin gene expression in human erythroid cells.
    Tang DC; Zhu J; Liu W; Chin K; Sun J; Chen L; Hanover JA; Rodgers GP
    Blood; 2005 Nov; 106(9):3256-63. PubMed ID: 15985540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and hydroxyurea-triggered induction of EGFP upon CRISPR/Cas9-mediated integration into the γ-globin gene of K562 cells.
    Jafari H; Hesami S; Safi M; Ghasemi F; Banan M
    Biotechnol Lett; 2019 Jul; 41(6-7):691-700. PubMed ID: 30941601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the
    Ghosh D; Panja A; Saha D; Banerjee U; Datta AK; Basu A
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):563-570. PubMed ID: 34406845
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
    Zein S; Li W; Ramakrishnan V; Lou TF; Sivanand S; Mackie A; Pace B
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1385-94. PubMed ID: 20975082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing Compounds.
    Durlak M; Fugazza C; Elangovan S; Marini MG; Marongiu MF; Moi P; Fraietta I; Cappella P; Barbarani G; Font-Monclus I; Mauri M; Ottolenghi S; Gasparri F; Ronchi A
    PLoS One; 2015; 10(10):e0141083. PubMed ID: 26509275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of beta-thalassemia with hydroxyurea (HU)--effects of HU on globin gene expression.
    Huang SZ; Ren ZR; Chen MJ; Xu HP; Zeng YT; Rodgers GP; Zeng FY; Schechter AN
    Sci China B; 1994 Nov; 37(11):1350-9. PubMed ID: 7865126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained enhancement of OCTN1 transporter expression in association with hydroxyurea induced γ-globin expression in erythroid progenitors.
    Walker AL; Ofori-Acquah SF
    Exp Hematol; 2017 Jan; 45():69-73.e2. PubMed ID: 27616638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir induces fetal hemoglobin via downregulation of γ-globin repressors, BCL11A and SOX6 trans-acting factors.
    Ali H; Khan F; Ghulam Musharraf S
    Biochem Pharmacol; 2021 Aug; 190():114612. PubMed ID: 34010599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cis-vaccenic acid induces differentiation and up-regulates gamma globin synthesis in K562, JK1 and transgenic mice erythroid progenitor stem cells.
    Aimola IA; Inuwa HM; Nok AJ; Mamman AI; Bieker JJ
    Eur J Pharmacol; 2016 Apr; 776():9-18. PubMed ID: 26879870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
    Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
    Ali H; Khan F; Musharraf SG
    Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.